Targeting PR1 in myeloid leukemia

Oncotarget. 2017 Dec 18;9(4):4280-4281. doi: 10.18632/oncotarget.23403. eCollection 2018 Jan 12.

Authors

Gheath Alatrash¹, Jeffrey J Molldrem¹, Muzaffar H Qazilbash¹

Affiliation

¹ Department of Stem Cell Transplantation and Cellular Therapy, Associate Professor of Medicine, Section of Transplant Immunology, Houston, TX, USA.

No abstract available

Keywords: AML; PR1; immunotherapy; leukemia; vaccine.

Publication types

Editorial